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TINJAUAN TERATOMA OVARI DALAM SEPULUH TAHUN PENGALAMAN 
HOSPITAL UNIVERSITI MALAYSIA 2003 HINGGA 2012 
 
Abstrak 
 
Pengenalan 
 
Kanser ovari adalah kanser keempat paling biasa berlaku dalam  kalangan wanita di 
Britain (United Kingdom) dan di Malaysia. Ia meliputi 6.5% jumlah pesakit wanita 
dengan kadar insiden sebanyak 8.6/ 100,000 dan merupakan unsur kematian dalam 
kalangan wanita di Malaysia selepas penyakit kanser paru-paru, payudara dan kolon. 
Teratoma ovari matan selalunya tidak merbahaya.Walaubagaimanapun ianya dikaitkan 
dengan transformasi sehingga 15% dan tidak bergantung kepada prosedur pre operatif 
diagnostik untuk mengesan transformasi ini.Teratoma tidak matang mewakili 3% 
daripada jumlah keseluruhan teratoma ovari tetapi mewakili 20% sel kuman malignan, 
dan ianya biasa berlaku dalam kalangan wanita berusia di bawah 20 tahun dan 
mempunyai  kemungkinan untuk mengalaminya semula.Pendekatan penjagaan 
kesuburan amat penting tetapi pada peringkat serius mungkin sukar dan akan 
membawah komplikasi kematian yang berkaitan dengan kemoterapi.  
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Objectif 
 
Kajian ini bertujuan untuk meninjau corak klinikal–patologi dan hasil pengurusan 
pesakit teratoma ovari di Hospital Universiti Sains Malaysia. 
 
 
Kaedah 
 
Sebanyak 160 kes dikesan dengan teratoma dan diuruskan di Hospital Universiti Sains 
Malaysia dari tahun 2003 sehingga 2012 ditinjau secara retrospektif.Senarai pesakit 
yang disahkan dengan diagnosis histologi didapati daripada rekod jabatan patologi dan 
fail mereka dikesan,data dikumpul dan dianalisa menggunakan SPSS 21. 
 
 
Keputusan 
 
Teratoma ovari dilihata dalam kalangan wanita berusia  4 ke 75 tahun dan paling biasa 
dalam kalangan wanita 21-40 tahun (59.4%), 74.4% sudah berkahwin dan 
kebanyakannya tidak pernah menggunakan pil kontraseptif oral kebanyakannya 
mempunyai  1- 4 orang anak ( 64%) dan menyusu  sekurang- kurangnya selama satu 
tahun. Sebanyak 53 ( 33.1 %) hamil ketika dikesan. Massa abdomen atau distensi dan 
kesakitan abdomen merupakan simpton utama 32 kes setiap gejala, tetapi 26.8 % 
dikesan secara kebetulan manakala 18 (11.3%) pesakit mengalami abdomen akut. 
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Lebih daripada separuh kes merupakan obes ( 57.5 %). Teratoma sistik merupakan jenis 
histologi paling biasa iaitu  91.9 %, monodermal 3.1% , tidak matang  2.5% dan 
transformasi malignan sebanyak 1.25 %. Ciri- ciri ultrasound adalah unilateral ( 67.5%), 
bilateral (8.8 %). Terdapat tumor sistik pejal dalam kebanyakan kes (54 %), 18.8% sistik 
asl, manakala 3.1merupakan tumor  pejal asal. Hanya dalam 38 kes (31.1 %) bahan 
ekogenik tidak menonjol diterangkan.Laparotomi merupakan pendekatan pembedahan 
paling biasa dalam 114 kes, penbuangan tumor di tempat yang sama dalam pembedahan 
Caesarean(LSCS) 34, kes pendekatan laparoskopik adalah 12 kes dengan kadar 
penumpahan 21.1%, 20.6% and 58.3% untuk laparotomi,LSCS dan pendekatan 
laparoscopik.Dua kes kemoterapi bantuan dan tempoh susulal adalah dalam 3 - 60 bulan 
dengann dua kes kedatangan semula teratoma ovari matang dikesan tetapi tiada 
berlakunya peritonise kimia. 
 
  
Kesimpulan 
 
Teratoma merupakan tumor ovari paling biasa dalam kalangan wanita dalam usia 
reproduksi,walaubagaimanapun,ditak ditemui perkaitan signifikan dengan faktor seperti 
status perkahwinan, pariti, penyusuan, penggunaan kontraseptif oral gabungan dan 
indeks jisim tubuh sekalipun dengan kehadiran faktor- faktor ini dalam majoriti kes,dan 
ini mungkin disebabkan oleh kekurangan kuasa bagi kajian ini bagi mengesan pakaitan 
tersebut. 
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Penjagaan kesuburan adalah perkaran penting,ultrasonografi adalah kaedah yang boleh 
dipercayai untuk mengesan dan memilih pesakit yang akan bersalin atau intervensi 
pembedihan,kajian ini juga mendedahkan,majoriti (112/160) kes.Terdapat keperluan 
untuk memperbaiki laporan sonografi dalam kes yang dikhuatiri teratoma ovari.12 kes 
teratoma ovari telah menjalani pembuangan laparoskopi tumor dengan kadar tumpahan 
58.1%,namun tiada diantara kes-kes ini mengalam semula kanser atau peritonitis kimia 
oleh itu pendekatan laparoskopi boleh dijadikan alternatif pendekatan tradisional 
laparotomi.  
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A REVIEW OF OVARIAN TERATOMA IN HUSM TEN YEARS 
EXPERIENCE: 2003 to 2012 
 
ABSTRACTS 
 
Introduction 
 
Ovarian cancer is the fourth most common cancer among women in United Kingdom 
(UK) and in Malaysia. It constituted 6.5% of total female cancer with age standardized 
incidence rate (ASR) of 8.6 per 100,000, and is a major source of morbidity and 
mortality among women coming only after cancers of lungs, breast and colon in 
Malaysia. Mature ovarian teratoma is commonly benign; however it is associated with 
malignant transformation in up to 15% and no reliable preoperative diagnostic 
procedures to detect this transformation. Immature teratoma represents 3% of total 
ovarian teratoma but constitutes 20% of germ cell malignancies, it occurs commonly 
among women below 20 years old and has tendency of recurrence. Fertility preservation 
approach of management is highly crucial but in advance stage may be difficult and 
occasionally the fatal complication associated with chemotherapy is a concern. 
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Objective  
 
We aim to review the clinico-pathological pattern and outcome of management of 
ovarian teratoma patients in Hospital Universiti Malaysia (HUSM). 
 
 
Methodology 
 
A total of 160 women diagnosed with ovarian teratoma and managed in HUSM from 
2003 to 2012 were reviewed retrospectively. List of patients with confirmed histological 
diagnosis was obtained from pathology department record and their folders were traced, 
data collected and analyzed using SPSS 21 software (Inc., Chicago, USA). 
 
 
Results 
 
Ovarian teratoma is seen from 4 years to 75 years old women and commonest among 
21-40 years age group (59.4%). Majority were married (74.4%) and most of them never 
use oral contraceptive pills (OCP), 64% have 1- 4 children and breast fed for at least one 
year and 53(33.1%) were pregnant during diagnosis. Abdominal mass or distension and 
abdominal pain were the commonest presenting symptoms in 32 in cases, 45 cases were 
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incidental diagnosis while 18 presented with acute abdomen. 43.1% of the cases were 
obese. Mature cystic teratoma is the commonest histological type (91.9%), monodermal 
3.1%, immature 2.5% while, malignant transformation and mixed germ teratoma have 
1.25% each. Ultrasound features were unilateral 108 (67.5%), bilateral 14 (8.8%). There 
were mixed solid cystic tumors in majority of cases 89(55.6%), 29(18.1%) were pure 
cystic while 4(2.5%) were pure solid tumors. Only in 38(31.1%) cases had discrete 
echogenic mass reported. Laparotomy was the commonest surgical approach 114 cases 
(71.3%), removal of tumor in the same setting during lower segment Caesarean section 
(LSCS) were 34 cases (21.3%) and laparoscopic approach was 12 cases (7.5%). The rate 
of spillage was found to be 21.1%, 20.6% and 58.3% for laparotomy, LSCS and 
laparoscopic approach respectively. Two cases had adjuvant chemotherapy with 
Bleomycine, Etoposide and Platinum regimen (BEP) involving one case of immature 
teratoma and the other of mature teratoma with malignant transformation. Follow up 
period was 3 -60 months and two cases of recurrent mature ovarian teratoma occurred 
but no chemical peritonitis reported. 
 
 
Conclusion 
 
Teratoma is the commonest ovarian tumor in the reproductive age women, however, we 
found no significant association with factors such as marital status, parity, breast 
feeding, use of combine oral contraceptive and body mass index despite the presence of 
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these factors in majority of our cases, this might be as a result of low power of the study 
to detect such an association. 
 Fertility conservation is a great concern; ultrasonography is a reliable means for 
diagnosing and careful selection of patients for expectant management or surgical 
intervention. This study reveals that majority (122/160) of ovarian teratoma cases had 
ultrasound done pre operatively and diagnosis of teratoma was suspected or made but 
only one out of many presumed pathognomic features of teratoma was reported in 
38/112 cases. As such there is need to improve in sonographic reporting of suspected 
cases of ovarian teratoma. Twelve cases of ovarian teratoma had laparoscopic removal 
of the tumor with 58.3% spillage rate, however none of the cases had a recurrence or 
chemical peritonitis therefore laparoscopic approach can be consider as an alternative to 
traditional laparotomy approach. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Overview of Ovarian cancer 
 
Ovarian cancer is the fourth most common cancer among women in UK and is a major 
source of morbidity and mortality. Each year in UK there are over 6,820 new cases 
(Coleman et al., 2011). Higher case fatality reflects a delay in diagnosis, since patients 
often present with non-specific symptoms, diagnosis is generally made when disease has 
spread to the peritoneal cavity.  About 65% of patients are diagnosed with advanced 
cancer, when 5 years survival is only 28%(Studd, 2005). It presents an increasing 
challenge to the gynecological oncologist due to the paucity of knowledge of etiological 
factors and by the failure to achieve dramatic reduction in mortality due to these 
neoplasm during the past 6 decades (Studd, 2005). According to Malaysia national 
cancer registry report 2005, ovarian cancer constituted 6.5% of total female cancer with 
age standardized incidence rate of 8.6 per 100,000.It is also a common cause of women 
death in Malaysia coming only after cancers of lungs, breast and Colon (Malaysia 
Ministry of Health 2007).  
 
About 90% of ovarian cancers are epithelial in origin, however in adolescents and 
children germ cell tumors formed up to 60% of ovarian malignancies.In contrast with 
epithelial ovarian cancers that arise from the surface coelomic epithelium, ovarian germ 
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cell malignancies are believed to originate from primordial germ cells that migrate into 
the gonadal ridge at 6 weeks of embryonic life. Consequently, ovarian germ cell tumors 
might exhibit a spectrum of histological differentiation that mimics a primitive 
developing embryo. For example, dysgerminoma appears to be descended from 
relatively undifferentiated cells, whereas yolk sac tumors show malignant change in a 
cell line committed to extraembryonic differentiation while immature teratoma are 
derived from cells predisposed to somatic (embryonic) differentiation and recapitulate 
tissue from all three primitive germ cell layers, ectoderm, endoderm, and mesoderm 
(Deligdisch, 2013). When considered together, the dysgerminoma, yolk sac tumor, 
immature teratoma, and their hybrid (mixed germ cell tumour) comprise more than 90% 
of malignant germ cell tumors. Non gestational choriocarcinoma, embryonal carcinoma, 
and polyembryoma manifest rarely as pure entities and comprise the remaining 5–10% 
(Smith et al., 2006). Although these tumors account for less than 5% of all ovarian 
cancers, their importance is greater than their numerical incidence implies because they 
occur in children and young women during the prime of life. The median age at 
presentation is 18 years, contrasting dramatically with perimenopausal or 
postmenopausal age associated with epithelial ovarian cancer. Symptoms usually 
indicate rapidly enlarging abdominopelvic masses. Approximately one-third of patients 
have ascites, and 10% present with peritonitis secondary to torsion, infection, or rupture 
of the ovarian tumor. Prepubertal patients might manifest signs of precocious puberty, 
such as breast development or vaginal bleeding, as a result of hormone production by the 
tumor  (Tewari et al., 2000). 
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1.2 Ovarian teratoma 
 
Ovarian teratomas are germ cell tumors that are formed by cells derived from more than 
one of the three primitive embryonic layers, i.e. ectoderm, mesoderm and endoderm. 
Clinically, ovarian teratoma can occur at any age and cases were reported between 2 and 
80 years of age, but frequently detected during child bearing years with median age of 
30 years (Bloomfield, 1987). Ovarian teratoma can be mature, immature, monodermal or 
specialized type of teratoma. 
 
 
1.2.1 Mature ovarian teratoma 
 
They affect a younger age group (mean age of 30 years) than epithelial ovarian 
neoplasm. It  constitutes 80% of total germ cell tumors and accounting for about 15% of 
total ovarian neoplasm, it is biologically benign in all ages and is commonest ovarian 
neoplasm removed at surgery  Mature teratoma are commonly unilateral but can be 
bilateral in 10% of cases and are mostly cystic although solid form can be found rarely 
(Kim et al., 2011). They composed of well differentiated derivatives from at least two of 
the three germ cell layers with predominance of ectodermal elements. Characteristically 
they are unilocular cysts containing hair and cheesy sebaceous material. On section, they 
reveal a thin wall lined by an opaque, gray-white, wrinkled epidermis. From this 
epidermis, hair shafts frequently protrude. Within the wall, it is common to find tooth 
structures and areas of calcification.(Koonings et al., 1989; Outwater et al., 2001).  
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1.2.2 Mature teratoma with malignant transformation 
 
Although mature teratoma is commonly benign it is associated with malignant 
transformation commonly reported as 1 -3% of cases although some isolated series 
reported up to 15% (Wei et al., 2001). Malignant transformation is seen commonly in 
more advanced age (post-menopausal) and is typically associated with poorer prognosis. 
It has also been noted that all applied preoperative diagnostic procedures are themselves 
too unreliable to exclude early stages of ovarian cancer arising from within a mature 
cystic teratoma (Christopherson and Councell, 1989; Papa et al., 2005). 
 
 
1.2.3 Immature teratoma 
 
 Immature teratoma differs from benign teratoma in that the component tissues resemble 
embryonic and immature fetal tissue, they may also contain mature tissues. They are 
defined by the World Health Organization (WHO) as a teratoma containing variable 
amount of immature embryonal type (generally) neuroectodermal tissues. It represents 
3% of total ovarian teratoma but constitutes 20% of germ cell malignancies and only 1% 
of total ovarian malignancy. These tumors usually grow rapidly, frequently penetrate the 
capsule and spread either locally or distantly. It is the third most common ovarian germ 
cell tumor(Saba et al., 2009). These tumors are bulky with smooth external surface. On 
section they have a predominantly solid structure but mixed solid cystic also occur. Hair, 
sebaceous material, cartilage, bone and calcification may be present.  
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 It is graded histologically according to the amount of primitive neuroectodermal tissue 
contents. Tumors with large areas of neuroblast are the highest grade and have worst 
prognosis. Although it has better prognosis than epithelial cancers especially in early 
stage with grade 1 disease, it also has tendency of recurrence especially within first 2 
year. Furthermore, it seen mainly among women below 20years of age where fertility 
preservation approaches of management is highly crucial. Late presentation with 
advance stage may occasionally make such conservation difficult (Outwater et al., 2001; 
Parkinson and Beilby, 1977). 
 
   Table 1.1 Grading Of Immature Teratoma 
Thurlbeck and  Scully 
grading system 
 
Grade 1 Cell well differentiated, rare small foci of embryonic 
tissues 
Grade 2 Moderate quantities of embryonic tissue, atypia and 
mitosis 
Grade 3  Large quantities of embryonal tissues, atypia and mitosis 
 
 Norris grading system Based on neuro epithelium 
Grade 1 
 
Some immaturity, neuroepithelium in low magnification 
40x 
Grade 2 Immaturity, neuroepithelium occupy<3 low power field 
Grade 3 Immaturity, neuroepithelium occupy >4 low 
magnification on single slide 
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 1.2.4 The specialized teratoma 
 
 Monodermal or specialized type of teratoma is a rare sub type of ovarian teratoma 
where there is monodermal differentiation of tissue element. Therefore, they usually 
contain only endodermal, ectodermal or mesodermal elements. The most common of 
which are struma ovarii and cacinoid. Up to 20% of teratomas contain thyroid tissue. 
Struma ovarii, defined as containing 50% or more thyroid tissue, is less common, 
accounting for approximately 5% of all ovarian teratomas Most patients with struma 
ovarii present with a pelvic mass, and pelvic ultrasonography characteristically shows a 
heterogeneous, solid mass, occasionally with ascites. They are always unilateral, 
although a contra lateral teratoma may be present (Yassa et al., 2008). Interestingly, 
these thyroidal neoplasms may hyper function, causing hyperthyroidism. The ovarian 
cacinoid, which presumably arises from intestinal epithelium in a teratoma, may also be 
functional, particularly if large (>7 cm) tumors, producing 5-hydroxytryptamine and the 
carcinoid syndrome. Even rarer is the strumal carcinoid, a combination of struma ovarii 
and carcinoid in the same ovary. About 2% of carcinoids metastasize. Other less 
common groups of monodermal tumors include central nervous system tumor, 
Cacinoma , Melanocytic, Sarcoma, Sebaceous tumor, Pituitary tumor and Retinal anlage 
groups.  
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1.3  Clinical features, complication  and treatment 
1.3.1 Clinical features 
 
Mature cystic teratomas of the ovary are often discovered as incidental findings on 
physical examination, during radiographic studies, or during abdominal surgery 
performed for other indications. Asymptomatic mature cystic teratomas of the ovaries 
have been reported at rates of 6-65% in various series. When symptoms are present, they 
may include abdominal pain, mass or swelling, and abnormal uterine bleeding. Bladder 
symptoms, gastrointestinal disturbances, and back pain are less frequent. When 
abdominal pain is present, it is usually constant and ranges from slight to moderate in 
intensity. Torsion and acute rupture commonly are associated with severe pain. 
Hormonal production is thought to account for cases of abnormal uterine bleeding, but 
histologic examination has not provided evidence to support this theory. Furthermore, 
the proportion of asymptomatic   patients increase significantly after 20 years of age 
because the older the age of diagnosis the more likely it is to be a benign tumor, 
occurrence of torsion has no age specific difference and tumor size tends to be larger in 
younger patients relative to older patients because of the more tendency to be an 
immature teratoma which grows more rapidly and tends to present with symptoms than  
mature teratoma (Kim et al., 2011). 
 
Ovarian teratoma is the commonest pathological tumor encounter in pregnancy and 
present in 0.3% of pregnancies from weeks 16-20 of gestation(De Santis et al., 2012).  
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The diagnosis of mature cystic teratomas during pregnancy presents the vexing problem 
of weighing the risks of surgery under general anesthetic against the risks of an 
untreated persistent adnexal mass (De Santis et al., 2012; Gasim et al., 2010).  Ovarian 
teratoma can also present with paraneoplstic syndromes, such as paraneoplastic limbic 
encephalitis even though it is rare, it’s recognition is extremely important because the 
only effective therapy is the surgical removal of the tumor. About 3–4% of this 
condition concerns ovarian teratoma and 50 -60% of cases involving teratoma are found 
to have malignant teratoma(Lee, 2012). Autoimmune haemolytic anemia (AIHA) can be 
induced  by a variety of causes including haematological neoplasm such as the 
lymphoma, however this condition is also reported to be associated with ovarian mature 
teratoma and the effective treatment was removal of the tumor (Sonn and Merritt, 2010; 
van Altena et al., 2008).  
 
 
1.3.2 Complication 
 
Torsion is a dreaded complication of ovarian teratoma. Gangrene or necrosis of the 
whole ovary frequently results from interference with its vascular supply thus requiring 
removal of the ovary involved which may be against the wish of any young woman 
planning many pregnancies in future. It may occur without apparent cause however, the 
initiating factors include intestinal peristalsis, alternate emptying and filling of the 
bladder, changes in size and position of uterus and the tumor itself during pregnancy, 
changes in the intra-abdominal pressure resulting from vomiting or coughing, trauma 
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and laxity of the abdominal wall. The unusual mobility of the tumours, especially small 
rather than large tumours with long pedicles will encourage torsion to occur (Lee et al., 
1989). Rupture is another complication occurring in 0.3 -2.5 % of ovarian teratoma 
which potentially cause serious peritonitis. The diagnosis may be difficult without index 
of suspicion because of bizarre presentation resembling gastro intestinal pathology 
(Iwata et al., 2009). 
 
 
1.3.3 Treatment 
 
Traditional therapy for mature teratoma has been cystectomy or oophorectomy via 
laparotomy. However operative laparoscopy has now become the popular approach 
because of the advantage of being minimally invasive with minimal compromise to the 
fertility. Surgical treatment of immature teratoma of the ovary depends on the extent of 
the disease, although bilateral involvement is rare but it is similar to epithelial cancer in 
terms of surgical staging and abdominal exploration. However since most of these 
patients are in their reproductive age and the tumor is excellently chemo sensitive, 
unilateral salphingoopherectomy with preservation of uterus and contra lateral ovary and 
tube is recommended practice whenever possible. Adjuvant chemotherapy is 
recommended except in stage 1, grade 1 tumor and  where complete excision is expected 
with low risk of recurrence (Rushdan M Noor, 2011).  
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1.4 Screening for ovarian cancer 
 
As compared to cervical cancer, ovarian cancer has no satisfactory screening method 
(Jacobs and Menon, 2004). Ovaries by the virtue of their location are inaccessible to 
early diagnosis of pathology. In addition there is no well recognized premalignant stage 
of ovarian cancer. Even where a premalignant stage is known as in borderline disease, 
the natural progression to malignancy is unknown and diagnosis is histological 
following operation. The screening methods are themselves insensitive, poorly 
predictive and in most cases inapplicable to general population. At present time there is 
no role for general population ovarian cancer screening in asymptomatic women(Menon 
and Jacobs, 2000). The result of United Kingdom collaborative trial on ovarian cancer 
screening (UKCTOCS) is awaited to throw more light on the screening. Therefore 
careful and effective management of diagnosed benign lesions that have tendency to 
transform into malignant ovarian cancers like mature ovarian teratoma is a wise 
decision. Pre operative diagnostic procedures and intraoperative findings are inadequate 
and unreliable in diagnosis of mature teratoma with malignant transformation especially 
in early stage, therefore clinic pathological pattern of pure mature teratoma and mature 
teratoma with malignant transformation is important in predicting those tumors with 
malignant transformation.  
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1.5 Rationale of Study 
 
It is important that hospital database regarding ovarian teratoma should be created and 
periodically updated as ovarian teratomas even though mostly are benign tumors, 
malignant transformation occurs in good proportion and current series indicate 
increasing trends of this transformation with potential to significantly add to the current 
burden of ovarian cancers . As earlier mentioned, all preoperative procedures are 
unreliable to diagnose this transformation. Moreover, immature teratoma is highly 
malignant cancer, it constitutes 20% of germ cell tumor and commonly diagnosed 
among women of less than 20 years of age where fertility conservation modality of 
treatment is crucial but occasionally this does not guaranteed absence of relapse 
requiring more radical approach which may compromise fertility. Chemotherapy has its 
own inherent complications especially in younger age women therefore careful selection 
of patients for adjuvant chemotherapy is also important, hence the need for a hospital 
data base for proper counseling of patients and to guide clinician decision. 
 
 Identifying factors associated with malignant teratoma as well as the outcome of 
management of these patients in our setting from this study, could translate into more 
accurate and early diagnosis of malignant teratoma by having higher index of suspicion 
from the clinical picture of our patients.   
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Appropriate and proper counseling of patients and their family members is crucial in 
management of patient with malignant ovarian teratoma which occurs commonly in 
reproductive age group and especially if in advance stage or in rare condition of bilateral 
tumour where decision of a treatment with fertility retaining capacity requires reasonable 
evaluation, this study may help us with local statistics for proper counseling. 
 
The hospital data base is necessary for a dynamic country equipped with facilities for 
this purpose like Malaysia, and HUSM is an integral part of this venture. The impact of 
this kind of study and others of the same nature will be at hospital level and assist in 
very important future planning at local and national levels. The easy availability of this 
data to health providers will have an overall effect of standardizing and improving the 
quality of care to the patients. Such a data base could also assist in directing further 
research into the issues surrounding ovarian teratoma. Many studies have been carried 
out regarding ovarian teratoma, however, studies to identify demographic and 
reproductive factors associated with ovarian teratoma as well as correlating the 
ultrasound features with histological types of teratoma were few and mostly carried out 
in other places, conclusion drawn from them may not be applicable to our patients, 
therefore highlighting the need for a local study. 
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1.6 Objectives of the study 
 General objectives 
 
 To determine clinico pathological pattern and outcome of management of ovarian 
teratoma 
 
  
Specific objectives 
 
1. To determine factors associated with ovarian teratoma. 
2. To describe clinical features of ovarian teratoma.  
3. To describe ultrasound findings of ovarian teratoma. 
4. To describe the outcome of treatment of benign and malignant teratoma. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 An over view of germ cell tumours 
 
 Ovarian germ cell neoplasms are thought to be derived from primitive germ cells of the 
embryonic gonad. They constitute the second largest group accounting for 15 to 20 
percent of all ovarian neoplasms.  Malignant germ cell tumours comprise less than five  
percent of all ovarian neoplasms in adult, however forms more than 60% of ovarian 
malignancies in children and adolescents (Gershenson et al., 1984). In 1973, the World  
Health Organization classified germ cell tumours as Dysgerminoma, Endodermal sinus 
tumour, Embryonal carcinoma, Polyembryoma, Choriocarcinoma, Teratomas including  
Immature, Mature and Monodermal, Mixed and Gonadoblastoma (Gershenson, 1993). 
This initiative represented a major advance in terms of standardization of nomenclature 
and histological criteria. 
 
  
2.2 Incidence of ovarian teratoma 
 
Mature cystic teratoma (MCT) is the commonest ovarian germ cell neoplasm (Rushdan 
M Noor, 2011). They mainly present in young women and by definition they are 
characterized by benign histological features. 
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 Teratoma with malignant transformation (TMT) predominantly(88%) to squamous cell 
carcinomas, may be observed in 1 -3 % (Petousis et al., 2013) although in some  reports 
up to 15% of mature teratomas and less commonly a number of other malignant tumors 
arising  from MCT have been reported, including  adenocacinoma, thyroid carcinoma, 
sebaceous  carcinoma, malignant melanoma and sarcoma(Wei et al., 2001). The 
incidence of ovarian teratoma is not uniform and  generally, it depends on the regions, 
for instance in 1968 to 1975  incidence of 46.4%  of total benign ovarian tumors was 
reported in  Kuala Lumpur   in contrast,  29% was reported in New York in the same 
year, which indicates varied incidence(Gosling, 1968).The racial distribution among the  
Malaysian ladies of benign ovarian teratoma was 77.1% for Malay ladies and 11.4%   
for each of Chinese and Indians  women respectively (Ong and Chan, 1977). In an effort 
to study the pattern of ovarian tumor among Malaysian women, a 2 year retrospective 
study 1986 to 1987, total of 280 cases were reviewed, 193 were benign, 81 were 
malignant and 6 cases were border line malignancy. The ovarian teratomas were the 
commonest benign tumors among Malays and Chinese while Serous cyst adenoma were 
the commonest among Indians (Ho, 1992). Bloomfied in 1987 reported mature ovarian 
teratoma as the commonest germ cell tumor and 1.38%  had malignant transformation  
(Bloomfield, 1987). Kim and his colleagues in 2011 found that mature teratoma formed 
93.9% while immature and malignant transformation accounted for 6.1% of all ovarian 
teratoma with  monodermal teratoma forming 2.8% (Kim et al., 2011). Shukiman’s 
series 1999 in HUSM reported teratoma to account for 71% of germ cell tumor, 
immature and mature teratoma with malignant transformation formed 4.5% each 
(Shukiman, 1999). 
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2.3 Histological Type of Ovarian Teratoma  
 
WHO classified ovarian teratoma generally into two categories, the first is biphasic or 
triphasic group which include immature and mature teratoma, the later which consists of 
solid, cystic and fetoform types. The second category is the monodermal and somatic 
type tumor associated with biphasic or triphasic teratoma (WHO 2003).Mixed germ cell 
tumor forms 10% of primitive germ cell tumors. The single most common combination 
is dysgerminoma and yolk sac tumor and bilaterality of the tumor occurs in up to 10% in 
this combination. Prognosis depends on the most malignant components (Rushdan M 
Noor, 2011).Ovarian teratoma as part of mixed germ cell tumor occurs in significant 
number of cases. Kurman 1976 found dysgerminoma in 80%,endodermal sinus 
70%,teratoma 53%,chorio carcinoma 20% and embryonal cancer 16% (Kurman and 
Norris, 1976). 
 
 
2.4 Etiology and Associated Factors 
 
 The word teratoma comes from the Greek word “teras” meaning monster, and “oma” 
meaning swelling. The origin of these cysts was considered to be evil, and early 
speculations include the invasion of a parasitic demon or the outcome of various forms 
of sexual misbehavior (Wheeler, 1983). Clinical and histological evidence is consistent 
with human ovarian teratomas having a germ cell origin. The most compelling reason 
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for believing this is the fact that teratomas are often  phenotypically different from their 
host, a situation most readily explained by postulating that one or more of the stages of 
meiosis has occurred during tumor development (Carritt et al., 1982). Parrington in 1984 
studied chromosomal and enzymes markers in 21 benign ovarian teratoma and reported 
markers heterozygous in the patient found to be completely homozygous in 52% of 
teratoma and completely heterozygous in 19%.The remainder shows mixture of the two, 
10% having homozygous centromeres and some heterozygous enzyme markers and 19% 
having heterozygous centromeres and some homozygous enzyme markers. These 
findings suggest that ovarian teratoma arise from germ cell in a number of different 
ways. Those with heterozygous centromeres thought to might have arisen from failure of 
meiosis I, some with homozygous centromeres must arise by failure of meiosis II, but 
because of the low level of heterozygous enzymes markers in this group substantial 
number are thought to arise by  duplication of mature ovum to give entirely homozygous 
genotype, genetically the female equivalent of the complete hydatidiform mole 
(Parrington et al., 1984). Ohama and colleaques study of immature teratoma for 
chromosomal heteromorphism, enzymes polymorphism and HLA specificity, confirmed 
Parrington earlier  report (Ohama et al., 1985). Surti in 1990 came up with the report 
consistent with earlier findings, following study of one hundred and two benign ovarian 
teratomas and two cases of immature teratoma. They karyotyped and scored teratoma 
cells for centromeric heteromorphism. They conclusively postulated five mechanisms of 
origin including meiosis I error, meiosis II error, endoreplication of haploid ovum, 
mitotic division of premeiotic germ cell, and fusion of two ova (Surti et al., 1990). 
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Lee and his co workers proposed the process of imperfect pathogenesis as one the 
mechanism of development of ovarian teratoma. In this theory, it is believed that 
teratoma arise from undifferentiated germ cells present in the developing gonad anlage. 
During normal development these cells originate from endoderm of yolk sac and migrate 
into the gonad at some later times. There because of an unknown inciting factors, they 
take part in a process of pathogenesis leading to formation of teratoma (Lee et al., 1997). 
 Many series suggest possibility of familial predisposition and association of ovarian 
teratoma with various demographic, obstetrics and gynecological factors as well as their 
similarities to testicular cancers especially with regards to age distribution and in utero 
hormonal exposure. A good number of report series of ovarian teratoma among the 
siblings of the patients, twins and triplets sisters together with theory of imperfect 
pathogenesis of ovarian teratoma suggest familial risk in ovarian teratoma (Baldwin, 
1994; Plattner and Oxorn, 1973). 
  
Westhoff in 1988 in one case control study identified higher socio economic status, 
single marital status or late marriage, low parity and excessive alcohol consumption to 
be associated with ovarian teratoma. Walker at the same time reported  in utero  
exposure to hormones such as the diethylstielbesterol (DES) or other pregnancy support 
hormones or inadvertent exposure to OCP during pregnancy as well as the maternal 
obesity to be associated with subsequent development of ovarian teratoma among the 
offspring from index pregnancy (Walker et al., 1988).  
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Margaret Booth report 1992 was consistent with Westerhoff’s in terms of association 
with infertility, however their series and Parrazini data in 1995 found no clear 
relationship with parity, marital status, OCP use, age at menarche, menstrual pattern or 
menopausal status (Booth et al., 1992; Parazzini et al., 1995). 
 
 
2.5 Clinical features 
 
Teratoma is a congenital tumor and thought to be present even before birth, however 
because of its slow growth nature it is not diagnosed until much later in childhood or in 
adulthood. It is often discovered incidentally during physical examination, radiographic 
studies, or abdominal surgery performed for other indications. The patients are usually 
of reproductive age group with mean age of 30 years, however postmenopausal women 
are also affected in significant proportion and present with symptoms suggestive of 
malignant tumor  (Hunter et al., 1988; Wei et al., 2001). When symptoms are present, 
the commonest may include abdominal pain or abdominal mass or swelling. Abnormal 
uterine bleeding, bladder symptoms, gastrointestinal disturbances and back pain are less 
frequent.  Torsion and acute rupture commonly are associated with severe pain (Ho, 
1992; Shukiman, 1999).  In contrast to the mature teratoma immature teratoma presents 
among younger than 20 years old women and because of its rapid growth, it has more 
symptoms and diagnose much earlier than the mature teratoma. 
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2.6 Ultrasound features 
 
Owing to their heterogeneous histological structures, cystic ovarian teratomas have 
variable appearance on sonography. Because of wide range of combinations of different 
tissues in teratoma their pattern mimics number of pathological pelvic masses. Therefore 
interpretation of sonographic features in terms of tissue characterization and 
ascertainment of a particular pattern as an ovarian teratoma can sometimes be confusing. 
However, with the refinement in the ultrasound technology and increasing experience, 
sonographic  signs suggestive of cystic teratoma has been recognized and knowledge 
about pathognomic pattern has accumulated (Caspi et al., 1996). 
 
The pathognomic features of ovarian teratoma from sonography has been known for 
quite some time, with earlier series reporting up to 85% rate of correct diagnosis 
(Guttman, 1977).These features include dermoid plug or Rokitansky plug which is seen 
as one or more highly echogenic nodules. The plug is produced by congimelurates 
within the lesion of fat and sebaceous material, hair, soft tissue, calcification and teeth. 
The size of the plug varies widely, in some tumors occupies only small portion while in 
others occupy almost entire volume of the lesion. This plug usually is the compelling 
observation leading to diagnosis of ovarian teratoma. Unfortunately features in other 
pelvic lesions can resamble this plug and can give diagnostic differentials such as 
haemorrhage in pelvic mass, exophytic lipomatous uterine mass, perforated appendicitis 
with appendiculith and adeno fibroma. 
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A less common perhaps more specific feature of cystic teratoma is discrete highly 
echogenic focus with posterior shadowing produced by ectopic teeth or bone fragment. 
Other features  include fine echogenic bands within the cystic area (representing hair)  
and presence of fat- fluid level (Hertzberg and Kliewer, 1996).  In 1996 also Caspi and 
his co workers studied prospectively 118 cases of echogenic adnexal masses which were 
confirmed post operatively by histology. Using the pathognomic echo pattern they were 
able to make correct diagnosis of cystic ovarian tertoma in 115 cases (97.45%) (Caspi et 
al., 1996). One of the recent series is that of Patel 1998 who demonstrated the positive 
predictive value for individual features was 80% for shadowing echodensity, 75% 
regionally bright echoes, 50% for echogenic bands and dots and 20% for fat fluid level. 
They concluded that any adnexal mass with 2 or more of the pathognomic features is 
diagnostic of cystic teratoma (Patel et al., 1998). 
 
 
2.7 Management 
 
Matured ovarian teratoma is a slow growing tumor with an annual growth rate in 
premenopausal women of 1.77 cm and 1.59 cm in postmenopausal therefore, Caspi and 
colleagues concluded that expectant management can be adopted in a small 
asymptomatic tumor of less than 6cm in diameter with annual growth rate of < 2cm by 
regular follow up ultrasound. This will enable women planning pregnancy to do so and 
avoid surgery which may impair fertility (Caspi et al., 1997; Caspi et al., 2000). Most 
affected women are of reproductive age, therefore conservative surgical excision or 
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cystectomy is warranted. Excision is indicated to determine the nature of suspected 
teratoma seen on ultrasound as persistent, heterogeneous, sometimes bilateral masses or 
because of pelvic pain with or without signs of rupture or torsion. Operative laparoscopy 
has now become a valid alternative to traditional laparotomy over last 15 years because 
of its recognized advantages, such as reduced adhesion formation (hence, reduced 
fertility compromise), less post-operative pain, shorter hospital stay and quick recovery. 
However, laparoscopic approach raises concerns. Firstly, intraoperative rupture, 
allowing contents to spills over the peritoneal surface and bowel which potentially lead 
to complications such as peritonitis, adhesions formation or spread of malignancy. Intra 
operative rupture during laparoscopic management of dermoid cyst appears to occur 
quite often (up to 80%) (Shawki et al., 2004).However, very few complications occur 
because of this. Extensive peritoneal washing during surgery to remove spillage contents 
may be responsible for this low complication rate. The second concern is that of 
possibility of recurrence after cystectomy by laparoscopic approach (Shawki et al., 2004; 
Yuen et al., 1997). 
 
Laparoscopic approach to remove dermoid cyst since its description in 1989 by Nezhat 
and colleagues is continuously proving to be safe and effective in this matter. It is 
proved to be safe even in pregnancy following patient selection and careful surgical 
technique (Parker et al., 1996). Many studies have shown that laparoscopic treatment of 
adnexal masses is safe even in postmenopausal women who are at greater risk of 
developing a malignant ovarian neoplasm (Ozturk and Sok, 2004).  
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Similar efficacy of laparascopic approach  to laparatomy with no recurrence of tumor or 
more complications seen in cases operated via laparoscopy as compared with 
laparotomy over five years of follow up has also been reported by Mais and colleagues 
(Briones-Landa et al., 2010; Mais et al., 2003).  A recent prospective study in Taiwan 
also confirmed favorable outcome and safety of laparoscopic approach in pregnancy 
(Koo et al., 2013). Safety has also been demonstrated in a patient with large tumor 15-40 
cm following careful selection of cases (Hong et al., 2012; Ye et al., 2012). The role of a 
frozen section and full staging operation in selected cases is recommended. This can be 
the case in younger patients of less 20 years with large tumor size. The frozen section 
shows mature cystic teratoma with preponderance of mature neural elements because 
foci of immature neural element can be readily be missed by frozen section (Einarsson et 
al., 2004). Mature ovarian  teratoma in postmenopausal women is not uncommon, some 
series reporting up to 7.6% of cases with malignant transformation occurring commonly 
in this group, therefore the surgical staging  and extensive excision especially in 
suspected malignant cases is recommended with or without adjuvant chemotherapy 
decision depends on the stage, grade and histological diagnosis (Wei et al., 2001). Mori 
and coworkers conclude that laparoscopic approach can also be use safely in patients of 
age less than 40 years with level of squamous cell cancer antigen of less than 2.5 ng/ml 
as it significantly differentiate between pure mature teratoma from those with malignant 
transformation(Mori et al., 2003). 
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Ovarian immature teratoma usually present with disease confined to the ovary and is 
typically radio resistant but highly chemo sensitive (Sen et al., 1988). Cure rates are high 
and therefore fertility sparing surgery is also recommended even when advanced disease 
is identified. Some patients however do recur and although generally salvage rate are 
high, there is a subgroup of chemo resistant patients who progress under treatment and 
succumb to their disease. Use of adjuvant chemotherapy especially in early stage of 
disease is controversial because even though the chemotherapeutic regimen primarily 
BEP spares fertility, significant side effects do occur(Weinberg et al., 2011). For 
example fatal Bleomycine pulmonary toxicity and secondary leukemia has been 
reported.Treatment recommendation include primary surgical staging procedure for all 
patients with immature teratoma, however most patients are diagnosed on final 
histopathology  report, therefore treatment decisions  are based commonly on pathology, 
imaging and tumour markers (Kollmannsberger et al., 1999; Simpson et al., 1998; 
Weinberg et al., 2011). Successful pregnancies have been reported following fertility 
preservation followed by combine chemotherapy even in advanced stage with high grade 
disease (Chen et al., 2007).  
 
Cushing suggest reserving adjuvant chemotherapy for only recurrent cases independent 
of the grade of tumor following complete resection especially in the children and 
adolescents (Cushing et al., 1999). However the current recommendation is that even 
after complete resection, recurrence of this tumor is not uncommon, therefore, all except 
stage 1 with grade 1 tumor should be given adjuvant chemotherapy. The combination of 
Bleomycine, Etoposides and Cisplatinum (BEP regimen) is now accepted by many.  
